Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
Krzysztof Jamroziak, MD, PhD
Advertisement
Articles by Krzysztof Jamroziak, MD, PhD
Advertisement
Latest Updated Articles
MRD Recurrence Shown to Precede Biochemical Relapse in Multiple MyelomaPublished: June 26th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Pembrolizumab/Enfortumab Vedotin in Muscle Invasive Bladder Cancer
2
Fertility-Sparing Surgery May Be Safe Despite Recurrence in Cervical Cancer
3
Subcutaneous Mosunetuzumab Earns EU Approval in R/R Follicular Lymphoma
4
Novel Agent Yields Promising Results in MAPK-Associated Solid Tumors
5
